Author

Rossarin Suwanarusk

University of OtagoORCID 0000-0002-7310-245XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Bruce RusselliD· 4 shared Bridget Lamont· 2 shared Georges SnounouiD· 2 shared Laurent RéniaiD· 2 shared Morad‐Rémy Muhsin‐SharafaldineiD· 2 shared Pablo Juan BifaniiD· 2 shared Adeline C. Y. ChuaiD· 1 shared Adeline Chiew Yen Chua· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

Bruce RussellORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologybioRxivPreprintAug 21, 2026

A chromosome-scale Plasmodium cynomolgi Berok genome reveals a distinct subtelomeric architecture and a highly diverged primate malaria lineage

Adeline C. Y. Chua, Vipin Narang, Eric Jit-Kai Lim…·Pablo Juan Bifani

DOI 10.64898/2026.08.21.746107

non-human primatewhole-genome sequencing

MicrobiologyMicrobiologyPeer-reviewedOct 13, 2025

Antiparasitic effect of peptoids against Cryptosporidium parvum

Bridget Lamont, Bruce Russell, Rossarin Suwanarusk…·Morad‐Rémy Muhsin‐Sharafaldine

This study identifies two peptoids, TM9 and TM19, with potent anti-Cryptosporidium parvum activity that does not harm host cells, suggesting their potential as new therapeutics for cryptosporidiosis.

2 citations

experimental assay

MicrobiologyFrontiers in MicrobiologyPeer-reviewedOct 4, 2024

Comparative efficacy and safety of anti-cryptosporidial agents: An in vitro study on Nitazoxanide, HFL, KDU731, and Paromomycin against Cryptosporidium parvum

Saffron T.G. Whitta, Bridget Lamont, Rossarin Suwanarusk…·Morad‐Rémy Muhsin‐Sharafaldine

This study compares the in vitro efficacy and safety of four anti-cryptosporidial agents against Cryptosporidium parvum using host cells and molecular assays.

5 citations

humanbulk RNA-seq

MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewedApr 8, 2024

Extended blood stage sensitivity profiles of Plasmodium vivax to doxycycline and tafenoquine using Plasmodium cynomolgi as a model

Peter R. Christensen, Rosy Cinzah, Rossarin Suwanarusk…·Bruce Russell

The paper uses Plasmodium cynomolgi to determine the delayed antimalarial effects of doxycycline and tafenoquine on P. vivax, finding IC50 values for doxycycline and tafenoquine.

1 citation

experimental assayhost-pathogen & immune response